Results 181 to 190 of about 74,631 (338)

Efficacy and Safety of Foslevodopa/Foscarbidopa Monotherapy in Patients with Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background As Parkinson's disease (PD) progresses, managing symptoms becomes increasingly difficult. Foslevodopa/foscarbidopa (LDp/CDp), a 24‐hour/day continuous subcutaneous infusion of levodopa/carbidopa (LD/CD) prodrugs, improves motor complications.
Jason Aldred   +11 more
wiley   +1 more source

Successful treatment of childhood onset symptomatic dystonia with levodopa. [PDF]

open access: bronze, 1993
Nicholas Fletcher   +3 more
openalex   +1 more source

Foot‐Tapping fMRI‐Guided rTMS Enhances Motor and Cognitive Functions in Parkinson's Disease: A Three‐Year Follow‐Up

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Zhiyi Hong   +7 more
wiley   +1 more source

A Systematic Review of the Parkinson's Foundation Hospital Care Recommendations

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background People with Parkinson's disease (PwP) face increased risks of complications and longer hospital stays compared to the general population. Four major factors contribute to increased morbidity and mortality during hospitalization: medication timing errors, administration of harmful medications, restricted mobility, and dysphagia ...
Ariane Veilleux Carpentier   +12 more
wiley   +1 more source

Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels [PDF]

open access: bronze, 1996
Jaime Kulisevsky   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy